Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 599-604

  Spadaro, Antonio ^a   Riccieri, Valeria ^a   Scrivo, Rossana ^a   Alessandri, Cristiano ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti CCP; Psoriatic arthritis; Synovial fluid

Indexed keywords

CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

ADOLESCENT; ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDES, CYCLIC; SYNOVIAL FLUID;

EID: 34748879993     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. NIENHUIS RLF, MANDENA EA: A new serum factor in patients with rheumatoid arthritis. The perinuclear factor. Ann Rheum Dis 1964; 23: 302-5.
2. SCHELLEKENS GA, DE JONG BAW, VAN DEN HOOGEN FHJ, VAN DE PUTTE LBA, VAN VENROOJ WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritic-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
3. RIEDEMANN JP, MUNOZ S, KAVANAUGH A: The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis-a systematic review. Clin Exp Rheumatol 2005; 23(Suppl. 39): S69-76.
4. VISSER H, LE CESSIE S, VOS K, BREEVELD FC, HAZES JMW: How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357-65.
5. MASSON-BESSIERE C, SEBBAG M, GIRBAL-NEUHAUSER E et al.: Tbe major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha and beta-chains of fibrin. J Immunol 2001; 166: 4177-84.
6. BAETEN D, PEENE I, UNION A et al.: Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium. Arthritis Rheum 2001; 44: 2255-62.
7. MASSON-BESSIERE C, SEBBAG M, DURIEUX JJ et al.: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000; 119: 544-52.
8. YOUINOU P, LE GOFF P, COLACO CB et al.: Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis 1985; 44: 450-4.
9. KIRSTEIN H, HJARVARD K, MØRK HANSEN T: Antikeratin antibodies in synovial fluid in rheumatoid arthritis. Acta Pathol Microbiol Scand 1989; 97: 185-9.
10. VOSSENAAR ER, SMEETS TJM, KRAAN MC, RAATS JM, VAN VENROOIJ WJ, TAK PP: The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004; 50: 3485-94.
11. LEE D, SCHUR PH: Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003; 62: 874-4.
12. VANDER CRUYSSEN B, HOFFMAN IEA, ZMIERCZAK H et al.: Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005; 64: 1145-9.
13. BOGLIOLO L, ALPINI C, CAPORALI R, SCIRÈ CA, MORATTI M, MONTECUCCO M: Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol 2005; 32: 511-5.
14. ALENIUS MG, BERGLIN E, RANTAPÄÄ DAHLQVIST S: Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint nflammation. Ann Rheum Dis 2006; 65: 398-400.
15. CASPI D, ANOUK M, GOLAN J et al.: Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Arthritis Rheum (Arthritis Care & Research) 2006; 55: 53-6.
16. KILLINGSWORTH LM: Clinical applications of protein determinations in biological fluids other than blood. Clin Chem 1982; 28: 1093-102.
17. HELLIWELL P, MARCHESONI A, PETERS M, BARKER M, AND WRIGHT V: A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991; 30: 339-45.
18. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. DOUGADOS M, VAN DER LINDEN S, JUHLIN R. AND THE EUROPEAN SPONDYLOARTHOPATHY STUDY GROUP: The European spondyloarthopathy Study Group preliminary criteria for the classification of spondyloarthopathy. Arthritis Rheum 1991; 34: 1218-27.
20. HELLIWELL PS, HETTHEN J, SOKOLL K et al.: Joint symmetry in early and late rheumatoid and psoriatic arthritis: Comparison with a mathematical model. Arthritis Rheum 2000; 43: 865-71.
21. MCGONAALE D, CANAGHAN P, EMERY P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999; 42: 1080-6.
22. VAN BOEKEL MAM, VOSSENAAR ER, VAN DEN HOOGEN FHJ, VAN VENROU WJ: Autoantibody systems in rheumStoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002; 4: 87-93.
23. WEINBERGER A, SIMKIN PA: Plasma proteins in synovial fluids of normal human joints. Semin Arthritis Rheum 1989; 19: 66-76.
24. VOSSENAAR ER, NUENHUIS S, HEKSEN MMA et al.: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2489-500.
25. GLADMAN DD, SHUKETT, RUSSELL ML, THORNE JC, SCHACHTER RK: Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987; 62: 127-41.
26. BOMBARDIERI M, ALESSANDRI C, LABBADIA G et al.: Role of anti-cyclic citrullinated peptide in discriminatine patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004; 6: 137-41.
27. MCHUGH NJ, BALACHRISHNAN C, JONES SM: Progression of peripheral joint disease in psoriatic arthritis: A 5-year prospective study. Rheumatology (Oxford) 2003; 42: 778-83.
28. TACCARI E, SPADARO A, RICCIERI V: Correlation between peripheral and axial radiological changes in patients with psoriatic polyarthritis. Rev Rhum 1996; 63: 17-23.